Effects of clinically used antioxidants in experimental pneumococcal meningitis

Auer, Marc; Pfister, Luz-Andrea; Leppert, David; Täuber, Martin G.; Leib, Stephen L. (2000). Effects of clinically used antioxidants in experimental pneumococcal meningitis. Journal of infectious diseases, 182(1), pp. 347-350. Cary, N.C.: The University of Chicago Press 10.1086/315658

	Text J Infect Dis.-2000-Auer-347-50.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (80kB)
Preview	Text 182-1-347.pdf - Other Available under License Publisher holds Copyright. Download (74kB) | Preview

Reactive oxygen intermediates mediate brain injury in bacterial meningitis. Several antioxidant drugs are clinically available, including N-acetylcysteine (NAC), deferoxamine (DFO), and trylizad-mesylate (TLM). The present study evaluated whether these antioxidants are beneficial in a model of pneumococcal meningitis. Eleven-day-old rats were infected intracisternally with Streptococcus pneumoniae and randomized to intraperitoneal treatment every 8 h with NAC (200 mg/kg), DFO (100 mg/kg), TLM (10 mg/kg), or saline (250 microL). TLM-treated animals showed a significantly reduced mortality compared with controls (P<.03). Meningitis led to extensive cortical injury at 22+/-2.2 h after infection (median, 14. 6% of cortex; range, 0-61.1%). Injury was significantly (P<.01) reduced to 1.1% (range, 0-34.6%) by NAC, to 2.3% (range, 0-19.6%) by DFO, and to 0.2% (range, 0-36.9%) by TLM (the difference was not significant among the 3 groups). None of the drugs reduced hippocampal injury. Thus, several clinically used antioxidants reduced cortical injury in experimental pneumococcal meningitis.

Interest & Impact

Downloads

213 since deposited on 04 Oct 2013
6 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item